1887
Research Open Access
Like 0

Abstract

Background

Global data highlight the disproportionate burden of HIV and sexually transmitted infections (STIs) among transgender individuals. However, scant data exist for both transgender and non-binary individuals in European HIV/STI surveillance.

Aim

To assess self-reported prevalence of HIV and bacterial STIs (syphilis, gonorrhoea, chlamydia) in the past 6 months among transgender and non-binary individuals, comparing the likelihoods of recent STIs between groups.

Methods

Using data from the cross-sectional PROTECT survey conducted in 20 European countries from October 2023 to April 2024, we analysed a subset of 452 participants, 178 transgender and 274 non-binary individuals. Logistic regression was used to compare the risk of each recent bacterial STI, and Poisson regression to compare the risk of the number of recent STIs.

Results

Among transgender individuals, 5 (2.8%) self-reported HIV infection, and recent STI prevalence was 6.7% for syphilis, 15.6% for gonorrhoea and 19.6% for chlamydia. For non-binary individuals, 15 (5.5%) self-reported HIV infection and recent STI prevalence was 15.0% for syphilis, 18.7% for gonorrhoea and 20.8% for chlamydia. Non-binary individuals had significantly higher risk for syphilis (aOR: 1.81; 95% CI: 1.01–4.05) and multiple recent STIs (aOR: 1.46; 95% CI: 1.11–1.91) compared with transgender individuals.

Conclusion

While both transgender and non-binary individuals showed high self-reported prevalence of HIV and bacterial STIs, non-binary individuals showed greater prevalence of STIs, particularly syphilis. Efforts aimed at HIV/STI prevention and surveillance should encourage inclusion of those who identify as non-binary and other gender-diverse individuals alongside transgender individuals to enhance the provision of tailored prevention and treatment services in Europe.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.48.2400347
2024-11-28
2024-12-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.48.2400347
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/48/eurosurv-29-48-7.html?itemId=/content/10.2807/1560-7917.ES.2024.29.48.2400347&mimeType=html&fmt=ahah

References

  1. Monro S. Non-binary and genderqueer: An overview of the field. Int J Transgenderism. 2019;20(2-3):126-31.  https://doi.org/10.1080/15532739.2018.1538841  PMID: 32999600 
  2. Stutterheim SE, van Dijk M, Wang H, Jonas KJ. The worldwide burden of HIV in transgender individuals: An updated systematic review and meta-analysis. PLoS One. 2021;16(12):e0260063.  https://doi.org/10.1371/journal.pone.0260063  PMID: 34851961 
  3. Motmans J, Nieder TO, Bouman WP. Transforming the paradigm of nonbinary transgender health: A field in transition. Int J Transgenderism. 2019;20(2-3):119-25.  https://doi.org/10.1080/15532739.2019.1640514  PMID: 32999599 
  4. Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, et al. Global health burden and needs of transgender populations: a review. Lancet. 2016;388(10042):412-36.  https://doi.org/10.1016/S0140-6736(16)00684-X  PMID: 27323919 
  5. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214-22.  https://doi.org/10.1016/S1473-3099(12)70315-8  PMID: 23260128 
  6. Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3) Suppl 3;S210-9.  https://doi.org/10.1097/QAI.0000000000001087  PMID: 27429185 
  7. MacCarthy S, Poteat T, Xia Z, Roque NL, Hyun Jin Kim A, Baral S, et al. Current research gaps: a global systematic review of HIV and sexually transmissible infections among transgender populations. Sex Health. 2017;14(5):456-68.  https://doi.org/10.1071/SH17096  PMID: 29216970 
  8. Drückler S, Daans C, Hoornenborg E, De Vries H, den Heijer M, Prins M, et al. HIV and STI positivity rates among transgender people attending two large STI clinics in the Netherlands. Sex Transm Infect. 2022;98(3):188-96.  https://doi.org/10.1136/sextrans-2020-054875  PMID: 33875565 
  9. Wang H, Daas CD, de Coul EO, Jonas KJ. MSM with HIV: Improving prevalence and risk estimates by a Bayesian small area estimation modelling approach for public health service areas in the Netherlands. Spat Spatio-Temporal Epidemiol. 2023;45:100577.  https://doi.org/10.1016/j.sste.2023.100577  PMID: 37301592 
  10. Van Gerwen OT, Jani A, Long DM, Austin EL, Musgrove K, Muzny CA. Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: a systematic review. Transgend Health. 2020;5(2):90-103.  https://doi.org/10.1089/trgh.2019.0053  PMID: 32656353 
  11. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017. Am J Public Health. 2019;109(1):e1-8.  https://doi.org/10.2105/AJPH.2018.304727  PMID: 30496000 
  12. Kirwan PD, Croxford S, Aghaizu A, Murphy G, Tosswill J, Brown AE, et al. Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing. HIV Med. 2022;23(11):1127-42.  https://doi.org/10.1111/hiv.13394  PMID: 36069144 
  13. Day S, Smith J, Perera S, Jones S, Kinsella R. Beyond the binary: sexual health outcomes of transgender and non-binary service users of an online sexual health service. Int J STD AIDS. 2021;32(10):896-902.  https://doi.org/10.1177/0956462420982830  PMID: 34106795 
  14. Skaletz-Rorowski A, Nambiar S, Basilowski M, Wach J, Kayser A, Kasper A, et al. Perspectives on trans-specific sexual health needs based on a free anonymous Online HIV/STI Risk Test (ORT) survey in Germany. Sex Transm Infect. 2022;98(8):622-3.  https://doi.org/10.1136/sextrans-2021-055356  PMID: 35064030 
  15. De Brier N, Van Schuylenbergh J, Van Remoortel H, Van den Bossche D, Fieuws S, Molenberghs G, et al. Prevalence and associated risk factors of HIV infections in a representative transgender and non-binary population in Flanders and Brussels (Belgium): Protocol for a community-based, cross-sectional study using time-location sampling. PLoS One. 2022;17(4):e0266078.  https://doi.org/10.1371/journal.pone.0266078  PMID: 35404977 
  16. Reisner SL, Chaudhry A, Cooney E, Garrison-Desany H, Juarez-Chavez E, Wirtz AL. ‘It all dials back to safety’: A qualitative study of social and economic vulnerabilities among transgender women participating in HIV research in the USA. BMJ Open. 2020;10(1):e029852.  https://doi.org/10.1136/bmjopen-2019-029852  PMID: 31959600 
  17. European Centre for Disease Prevention and Control (ECDC). HIV/AIDS surveillance in Europe 2023 (2022 data). Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2023-2022-data
  18. European Centre for Disease Prevention and Control (ECDC). STI cases on the rise across Europe. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/news-events/sti-cases-rise-across-europe#:~:text=In%202022%2C%20the%20number%20of,and%20chlamydia%20cases%20by%2016%25
  19. Tordoff DM, Minalga B, Gross BB, Martin A, Caracciolo B, Barbee LA, et al. Erasure and health equity implications of using binary male/female categories in sexual health research and human immunodeficiency virus/sexually transmitted infection surveillance: recommendations for transgender-inclusive data collection and reporting. Sex Transm Dis. 2022;49(2):e45-9.  https://doi.org/10.1097/OLQ.0000000000001533  PMID: 34407018 
  20. De Santis JP. HIV infection risk factors among male-to-female transgender persons: a review of the literature. J Assoc Nurses AIDS Care. 2009;20(5):362-72.  https://doi.org/10.1016/j.jana.2009.06.005  PMID: 19732695 
  21. Nuttbrock L, Hwahng S, Bockting W, Rosenblum A, Mason M, Macri M, et al. Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. J Acquir Immune Defic Syndr. 2009;52(3):417-21.  https://doi.org/10.1097/QAI.0b013e3181ab6ed8  PMID: 19550351 
  22. McNulty A, Bourne C. Transgender HIV and sexually transmissible infections. Sex Health. 2017;14(5):451-5.  https://doi.org/10.1071/SH17050  PMID: 28838351 
  23. Beckham SW, Glick J, Malone J, Rich AJ, Wirtz A, Baral S. HIV/AIDS among sexual and gender minority communities globally. In: Hwahng SJ, Kaufman MR, editors. Global LGBTQ health: research, policy, practice, and pathways. Cham: Springer International Publishing; 2024. p. 183-220.
  24. Wang H, Jonas KJ, Guadamuz TE. Chemsex and chemsex associated substance use among men who have sex with men in Asia: A systematic review and meta-analysis. Drug Alcohol Depend. 2023;243:109741.  https://doi.org/10.1016/j.drugalcdep.2022.109741  PMID: 36630807 
  25. PROTECT. PROTECT. Maastricht: Maastricht University; 2024. Available from: https://protect-study.eu
  26. Kolstee J, Wang H, Zimmermann H, Schroeder M, Appiah A, Brown C, et al. Kai J Jonas. Design and Methods of the “Understanding pre-exposure prophylaxis modalities for HIV prevention in European communities” (PROTECT) Survey. Preprint. MedRxiv.  https://doi.org/10.1101/2024.11.04.24316697 
  27. Schudson ZC, Morgenroth T. Non-binary gender/sex identities. Curr Opin Psychol. 2022;48:101499.  https://doi.org/10.1016/j.copsyc.2022.101499  PMID: 36401906 
  28. Klein PW, Psihopaidas D, Xavier J, Cohen SM. HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration’s Ryan White HIV/AIDS Program: A retrospective study. PLoS Med. 2020;17(5):e1003125.  https://doi.org/10.1371/journal.pmed.1003125  PMID: 32463815 
  29. UNAIDS. HIV and transgender and other gender-diverse people. Geneva: UNAIDS; 2021. Available from: https://www.unaids.org/sites/default/files/media_asset/04-hiv-human-rights-factsheet-transgender-gender-diverse_en.pdf
  30. Wang H, Molina J-M, Dray-Spira R, Schmidt AJ, Hickson F, van de Vijver D, et al. Spatio-temporal changes in pre-exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation. J Int AIDS Soc. 2023;26(5):e26089.  https://doi.org/10.1002/jia2.26089  PMID: 37221971 
  31. UNAIDS. Global AIDS Strategy 2021-2026 — End Inequalities. End AIDS. Geneva: UNAIDS; 2021. Available from: https://www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy
  32. Gültzow T, Neter E, Zimmermann H. Making research look like the world looks: introducing the ‘inclusivity & diversity add-on for preregistration forms’ developed during an EHPS2022 pre-conference workshop. Eur Health Psychol. 2023;23(4). ISSN: 2225-6962.
  33. Kojima N, Davey DJ, Klausner J. Meta-analysis finds association between pre-exposure prophylaxis to prevent human immunodeficiency virus (HIV) infection and increased risk of sexually transmitted infection acquisition among men who have sex with men. Open Forum Infect Dis. 2016;3(suppl_1):504.  https://doi.org/10.1093/ofid/ofw172.367 
  34. Bosetti D, Mugglin C, Calmy A, Cavassini M, Stöckle M, Braun D, et al. , Swiss HIV Cohort Study. Risk factors and incidence of sexually transmitted infections in the Swiss HIV cohort study. Open Forum Infect Dis. 2022;9(12):ofac592.  https://doi.org/10.1093/ofid/ofac592  PMID: 36504700 
  35. McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, et al. Comparison of trends in rates of sexually transmitted infections before vs after initiation of hiv preexposure prophylaxis among men who have sex with men. JAMA Netw Open. 2020;3(12):e2030806.  https://doi.org/10.1001/jamanetworkopen.2020.30806  PMID: 33355675 
  36. Reisner SL, Hughto JMW. Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample. PLoS One. 2019;14(8):e0221583.  https://doi.org/10.1371/journal.pone.0221583  PMID: 31454395 
  37. Pöge K, Dennert G, Koppe U, Güldenring A, Matthigack EB, Rommel A. The health of lesbian, gay, bisexual, transgender and intersex people. J Health Monit. 2020;5(Suppl 1):2-27. PMID: 35146279 
  38. Appenroth MN, Marcus U, Albrecht S, Jansen K, Gunsenheimer-Bartmeyer B, Bremer V, et al. Similar sexual behaviour yet different outcomes: comparing trans and gender diverse and cis PrEP users in Germany based on the outcomes of the PrApp study. Sexes. 2022;3(1):178-88.  https://doi.org/10.3390/sexes3010014 
  39. Appenroth MN, Koppe U, Hickson F, Schink S, Hahne A, Schmidt AJ, et al. Sexual happiness and satisfaction with sexual safety among German trans men who have sex with men: results from EMIS-2017. J Int AIDS Soc. 2022;25(Suppl 5) Suppl 5;e25992.  https://doi.org/10.1002/jia2.25992  PMID: 36225154 
  40. Fauk NK, Kustanti CY, Wulandari R, Damayani AD, Mwanri L. Societal determinants of HIV vulnerability among clients of female commercial sex workers in Indonesia. PLoS One. 2018;13(11):e0207647.  https://doi.org/10.1371/journal.pone.0207647  PMID: 30462714 
  41. Viswasam N, Rivera J, Comins C, Rao A, Lyons CE, Baral S. The epidemiology of HIV among sex workers around the world: implications for research, programmes, and policy. In: Goldenberg SM, Morgan Thomas R, Forbes A, Baral S, editors. Sex work, health, and human rights: global inequities, challenges, and opportunities for action. Cham: Springer International Publishing; 2021. p. 15-39.
  42. Fajans P, Ford K, Wirawan DN. AIDS knowledge and risk behaviors among domestic clients of female sex workers in Bali, Indonesia. Soc Sci Med. 1995;41(3):409-17.  https://doi.org/10.1016/0277-9536(94)00327-P  PMID: 7481934 
/content/10.2807/1560-7917.ES.2024.29.48.2400347
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error